Tenax Therapeutics Stock (NASDAQ:TENX)


RevenueOwnershipFinancialsChart

Previous Close

$4.39

52W Range

$2.77 - $61.20

50D Avg

$3.82

200D Avg

$4.27

Market Cap

$15.29M

Avg Vol (3M)

$526.38K

Beta

2.21

Div Yield

-

TENX Company Profile


Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

5

IPO Date

Apr 04, 1994

Website

TENX Performance


TENX Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$-8.23M$-11.05M$-32.73M
Net Income$-7.71M$-11.04M$-32.73M
EBITDA$7.71M$-10.93M$-32.36M
Basic EPS$-2.48K$-7.51$-31.81
Diluted EPS$-2.48K$-7.51$-31.81

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 16Mar 21, 17 | 10:43 AM
Q3 16Nov 10, 16 | 2:27 PM
Q2 16Dec 15, 15 | 11:54 AM

Peer Comparison


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
BWVOnconetix, Inc.
ENSCEnsysce Biosciences, Inc.
PXMDPaxMedica, Inc. Common Stock
ADTXAditxt, Inc.
REVBRevelation Biosciences, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
HILSTharimmune, Inc.
DRMADermata Therapeutics, Inc.
VRAXVirax Biolabs Group Limited
ALLRAllarity Therapeutics, Inc.
CYTOAltamira Therapeutics Ltd.
NRBONeuroBo Pharmaceuticals, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
WINTWindtree Therapeutics, Inc.
UNCYUnicycive Therapeutics, Inc.
BXRXBaudax Bio, Inc.